Crystalline forms or amorphous forms of bisdiazabicyclic compounds or salts thereof
AssigneesAscentage Pharma (Suzhou) Co., Ltd., Ascentage Pharma Group Corp Limited
InventorsJianfeng Wen, Yanqiong Lin, Tianzhu Wu, Minmin Cai, Zongbin Li, Weidong Li
Life of this patent
Estimating the term…
Abstract
Crystallines form or amorphous forms of bisdiazabicyclic compounds or salts thereof for the treatment and/or prevention of diseases or disorders related to hepatitis virus, and a preparation method and application thereof are provided. The crystalline forms or amorphous forms involved provide important reference value for the development and utilization of drugs in the future.
Claims20
A crystalline or amorphous form of compound 1:
- wherein the crystalline or amorphous form of compound 1 is
- crystalline form I characterized by an X-ray powder diffraction pattern which comprises peaks at 7.93±0.2°, 9.60±0.2°, 11.27±0.2°, 15.73±0.2°, 18.63±0.2°, and 19.22±0.2° in 2θ;
- and optionally has one or more peaks at 11.92±0.2°, 12.52±0.2°, and 16.72±0.2° in 2θ;
- or
- crystalline form II characterized by an X-ray powder diffraction pattern which comprises peaks at 5.80±0.2° and 7.68±0.2° in 2θ;
- or
- crystalline form III characterized by an X-ray powder diffraction pattern which comprises peaks at 7.83±0.2°, 9.78±0.2°, 11.78±0.2°, 19.32±0.2°, and 19.68±0.2° in 2θ;
- or
- amorphous form XIV characterized by an X-ray powder diffraction pattern as shown in FIG. 40, and optionally has the following characteristics:
- 1) In a TGA plot, there is a weight loss of 4.2±0.2% by weight before 130° C.;
- 2) In a mDSC curve, there is a glassy transition temperature at the midpoint temperature of 145.2±2.0° C.;
- 3) a TGA plot as shown in FIG. 41;
- and/or
- 4) a mDSC curve as shown in FIG. 42.
A crystalline or amorphous form of a salt of compound 1:
- wherein the crystalline or amorphous form of the salt of compound 1 is
- amorphous form IV of compound 1 monohydrochloride, characterized by an X-ray powder diffraction pattern as shown in FIG. 10, and optionally has the following characteristics:
- 1) In a TGA plot, there is a weight loss of 7.9±0.2% by weight before 150° C.;
- 2) In a mDSC curve, there is a glassy transition temperature at the midpoint temperature of 184.6±2.0° C.;
- 3a TGA plot as shown in FIG. 11;
- and/or
- 4) a mDSC curve as shown in FIG. 12;
- or
- amorphous form VI of compound 1 sulfate, characterized by an X-ray powder diffraction pattern as shown in FIG. 16, and optionally has the following characteristics:
- 1) In a TGA plot, there is a weight loss of 9.6±0.2% by weight before 150° C.;
- 2In a mDSC curve, there is a glassy transition temperature at the midpoint temperature of 207.2+2.0° C.;
- 3) a TGA plot as shown in FIG. 17;
- and/or
- 4) a mDSC curve as shown in FIG. 18;
- or
- amorphous form VII of compound 1 phosphate, characterized by an X-ray powder diffraction pattern as shown in FIG. 19, and optionally has the following characteristics:
- 1) a TGA plot, there is a weight loss of 4.5±0.2% by weight before 150° C.;
- 2) In a mDSC curve, there is a glassy transition temperature at the midpoint temperature of 176.0±2.0° C.;
- 3) a TGA plot as shown in FIG. 20;
- and/or
- 4) a mDSC curve as shown in FIG. 21;
- or
- amorphous form VIII of compound 1 mesylate, characterized by an X-ray powder diffraction pattern as shown in FIG. 22, and optionally has the following characteristics:
- 1) In a TGA plot, there is a weight loss of 5.2±0.2% by weight before 150° C.;
- 2) In a mDSC curve, there is a glassy transition temperature at the midpoint temperature of 172.7±2.0° C.;
- 3) a TGA plot as shown in FIG. 23;
- and/or
- 4) a mDSC curve as shown in FIG. 24;
- or
- amorphous form IX of compound 1 maleate, characterized by an X-ray powder diffraction pattern as shown in FIG. 25, and optionally has the following characteristics:
- 1) In a TGA plot, there is a weight loss of 3.7±0.2% by weight before 150° C.;
- 2) In a mDSC curve, there is a glassy transition temperature at the midpoint temperature of 163.6±2.0° C.;
- 3) a TGA plot as shown in FIG. 26;
- and/or
- 4) a mDSC curve substantially as shown in FIG. 27;
- or
- amorphous form X of compound 1 tartrate, characterized by an X-ray powder diffraction pattern as shown in FIG. 28, and optionally has the following characteristics:
- 1) In a TGA plot, there is a weight loss of 8.3±0.2% by weight before 150° C.;
- 2) In a mDSC curve, there is a glassy transition temperature at the midpoint temperature of 163.9±2.0° C.;
- 3) a TGA plot as shown in FIG. 29;
- and/or
- 4) a mDSC curve as shown in FIG. 30;
- or
- amorphous form XI of compound 1 benzoate, characterized by an X-ray powder diffraction pattern as shown in FIG. 31, and optionally has the following characteristics:
- 1) In a TGA plot, there is a weight loss of 9.1±0.2% by weight before 150° C.;
- 2) In a mDSC curve, there is a glassy transition temperature at the midpoint temperature of 143.8±2.0° C.;
- 3) a TGA plot as shown in FIG. 32;
- and/or
- 4) a mDSC curve as shown in FIG. 33;
- or
- amorphous form XII of compound 1 succinate, characterized by an X-ray powder diffraction pattern as shown in FIG. 34, and optionally has the following characteristics:
- 1) In a TGA plot, there is a weight loss of 3.5±0.2% by weight before 150° C.;
- 2) In a mDSC curve, there is a glassy transition temperature at the midpoint temperature of 138.9±2.0° C.;
- 3) a TGA plot as shown in FIG. 35;
- and/or
- 4) a mDSC curve as shown in FIG. 36;
- or
- amorphous form XIII of compound 1 acetate, characterized by an X-ray powder diffraction pattern as shown in FIG. 37, and optionally has the following characteristics:
- 1) In a TGA plot, there is a weight loss of 8.0±0.2% by weight before 150° C.;
- 2) In a mDSC curve, there is a glassy transition temperature at the midpoint temperature of 137.9±2.0° C.;
- 3) a TGA plot as shown in FIG. 38;
- and/or
- 4) a mDSC curve as shown in FIG. 39;
- or
- amorphous form XV of compound 1 mono-p-toluenesulfonate, characterized by an X-ray powder diffraction pattern as shown in FIG. 43, and optionally has the following characteristics:
- 1) In a TGA plot, there is a weight loss of 2.55±0.2% by weight before 127° C.;
- and a weight loss of 2.51±0.2% by weight between 127° C. and 222° C.;
- 2) In a mDSC curve, there is a glassy transition temperature at the midpoint temperature of 150.82±2.0° C.;
- 3) a TGA plot as shown in FIG. 44;
- and/or
- 4) a mDSC curve as shown in FIG. 45;
- or
- the amorphous form XVI of compound 1 di-p-toluenesulfonate, characterized by an X-ray powder diffraction pattern as shown in FIG. 46, and optionally has the following characteristics:
- 1) In a TGA plot, there is a weight loss of 2.97±0.2% by weight before 125° C.;
- 2) In a mDSC curve, there is a glassy transition temperature at the midpoint temperature of 168.02±2.0° C.;
- 3) a TGA plot as shown in FIG. 47;
- and/or
- 4) a mDSC curve as shown in FIG. 48;
- or
- amorphous form XVII of compound 1 diphosphate characterized by an X-ray powder diffraction pattern as shown in FIG. 49, and optionally has the following characteristics:
- 1) In a TGA plot, there is a weight loss of 1.46±0.2% by weight before 140° C.;
- 2) In a mDSC curve, there is a glassy transition temperature at the midpoint temperature of 177.83±2.0° C.;
- 3) a TGA plot as shown in FIG. 50;
- and/or
- 4) a mDSC curve as shown in FIG. 51;
- or
- crystalline form XVIII of compound 1 dimethanesulfonate, characterized by an X-ray powder diffraction pattern which has at least one or two peaks at 3.94±0.2°, 5.53±0.2°, 11.45±0.2°, 15.25±0.2°, and 20.51±0.2° in 2θ;
- or
- amorphous form XIX of compound 1 monooxalate, characterized by an X-ray powder diffraction pattern as shown in FIG. 55, and optionally has the following characteristics:
- 1) In a TGA plot, there is a weight loss of 3.63±0.2% by weight before 105° C.;
- and a weight loss of 10.4±0.2% by weight between 105° C. and 242° C.;
- 2) In a mDSC curve, there is a glassy transition temperature at the midpoint temperature of 100.62±2.0° C.;
- 3) a TGA plot as shown in FIG. 56;
- and/or
- 4) a mDSC curve as shown in FIG. 57;
- or
- amorphous form XX of compound 1 dioxalate, characterized by an X-ray powder diffraction pattern as shown in FIG. 58, and optionally has the following characteristics:
- 1) In a TGA plot, there is a weight loss of 3.52±0.2% by weight before 122° C.;
- and a weight loss of 11.6±0.2% by weight between 122° C. and 236° C.;
- 2) In a mDSC curve, there is a glassy transition temperature at the midpoint temperature of 97.8±2.0° C.;
- 3) a TGA plot as shown in FIG. 59;
- and/or
- 4) a mDSC curve as shown in FIG. 60;
- or
- amorphous form XXI of compound 1 dimaleate, characterized by an X-ray powder diffraction pattern as shown in FIG. 61, and optionally has the following characteristics:
- 1) In a TGA plot, there is a weight loss of 2.29±0.2% by weight before 117° C.;
- and a weight loss of 8.33±0.2% by weight between 117° C. and 216° C.;
- 2) In a mDSC curve, there is a glassy transition temperature at the midpoint temperature of 142.29±2.0° C.;
- 3) a TGA plot as shown in FIG. 62;
- and/or
- 4) a mDSC curve as shown in FIG. 63;
- or
- amorphous form XXII of compound 1 ditartrate, characterized by an X-ray powder diffraction pattern as shown in FIG. 64, and optionally has the following characteristics:
- 1) In a TGA plot, there is a weight loss of 3.14±0.2% by weight before 127.5° C.;
- and a weight loss of 15.15±0.2% by weight between 127.5° C. and 272.5° C.;
- 2) In a mDSC curve, there is a glassy transition temperature at the midpoint temperature of 155.97±2.0° C.;
- 3) a TGA plot as shown in FIG. 65;
- and/or
- 4) a mDSC curve as shown in FIG. 66;
- or
- amorphous form XXIII of compound 1 disulfate, characterized by an X-ray powder diffraction pattern as shown in FIG. 67, and optionally has the following characteristics:
- 1) In the TGA plot, there is a weight loss of 4.77±0.2% by weight before 100° C.;
- 2) In the mDSC curve, there is a glassy transition temperature at the midpoint temperature of 174.60±2.0° C.;
- 3) the TGA plot as shown in FIG. 68;
- and/or
- 4) the mDSC curve as shown in FIG. 69.
An amorphous form of a salt of compound 1:
- wherein the amorphous form of the salt of compound 1 amorphous form V of compound 1 dihydrochloride, characterized by an X-ray powder diffraction pattern as shown in FIG. 13, and optionally has the following characteristics:
- 1) In a TGA plot, there is a weight loss of 6.6±0.2% by weight before 150° C.;
- 2) In a mDSC curve, there is a glassy transition temperature at the midpoint temperature of 213.0±2.0° C.;
- 3) a TGA plot as shown in FIG. 14;
- and/or
- 4) a mDSC curve as shown in FIG. 15.
Dependencies are inferred from the claim text.